Evidence map›Paper›PMID 23752311›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replication.

Engin Gürlevik, Peter Schache, Anneliese Goez, Arnold Kloos, Norman Woller, Nina Armbrecht, Michael P Manns, Stefan Kubicka, Florian Kühnel

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Genome-editing Technologies for Gene and Cell Therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Engin GürlevikClinic for Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl Neuberg Street 1, 30625 Hannover, Germany.
Peter Schache
Anneliese Goez
Arnold Kloos
Norman Woller
Nina Armbrecht
Michael P Manns
Stefan Kubicka
Florian Kühnel
Medizinische Hochschule Hannover · DEReutlingen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meganucleases can specifically cleave long DNA sequence motifs, a feature that makes them an ideal tool for gene engineering in living cells. In a proof-of-concept study, we investigated the use of the meganuclease I-Sce I for targeted virus self-disruption to generate high-specific oncolytic viruses. For this purpose, we provided oncolytic adenoviruses with a molecular circuit that selectively responds to p53 activation by expression of I-Sce I subsequently leading to self-disruption of the viral DNA via heterologous I-Sce I recognition sites within the virus genome. We observed that virus replication and cell lysis was effectively impaired in p53-normal cells, but not in p53-dysfunctional tumor cells. I-Sce I activity led to effective intracellular processing of viral DNA as confirmed by detection of specific cleavage products. Virus disruption did not interfere with E1A levels indicating that reduction of functional virus genomes was the predominant cause for conditional replication. Consequently, tumor-specific replication was further enhanced when E1A expression was additionally inhibited by targeted transcriptional repression. Finally, we demonstrated p53-dependent oncolysis by I-Sce I-expressing viruses in vitro and in vivo, and demonstrated effective inhibition of tumor growth. In summary, meganuclease-mediated virus cleavage represents a promising approach to provide oncolytic viruses with attractive safety profiles.

Indexed as

Virus ReplicationAdenoviridaeAdenovirus E1A ProteinsCells, CulturedDeoxyribonucleases, Type II Site-SpecificDNA CleavageDNA, ViralGenetic VectorsHep G2 CellsHumansOncolytic VirusesSaccharomyces cerevisiae ProteinsTumor Cells, CulturedAdenovirus E1A ProteinsDeoxyribonucleases, Type II Site-SpecificDNA, ViralSaccharomyces cerevisiae ProteinsSCEI protein, S cerevisiae

Identifiers

PMID23752311
PMCPMC3776629
OpenAlexW2030600497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.